This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Claire McCluskie has worked within Ideagen’s life sciences team for over three years. During that time she has built a deep understanding of the industry demands and requirements, particularly in the topics of validation and data integrity. Aligning her knowledge of the industry and Ideagen’s products and services to the business needs of the industry is a key objective of her role.
With ISO 13485:2016 published and being implemented, many medical device customers are experiencing some uncertainty about the impact one of the key changes may have on their business: computer software validation.